|
1
|
Sathornsumetee S and Rich JN: New
treatment strategies for malignant gliomas. Expert Rev Anticancer
Ther. 6:1087–1104. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu L, Zhang Y, Zhu K, Song L, Tao M,
Huang P and Pan Y: Resveratrol inhibits glioma cell growth via
targeting LRIG1. J BUON. 23:403–409. 2018.PubMed/NCBI
|
|
3
|
Wang Y and Lan Q: Long non-coding RNA
AFAP1-AS1 accelerates invasion and predicts poor prognosis of
glioma. Eur Rev Med Pharmacol Sci. 22:5223–5229. 2018.PubMed/NCBI
|
|
4
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reid IR: Short-term and long-term effects
of osteoporosis therapies. Nat Rev Endocrinol. 11:418–428. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu
S, Zhang A, Jia Z, Wang G, Yu S, et al: LncRNA profile of
glioblastoma reveals the potential role of lncRNAs in contributing
to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012.
2012.PubMed/NCBI
|
|
7
|
Maher EA, Furnari FB, Bachoo RM, Rowitch
DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: Genetics
and biology of a grave matter. Genes Dev. 15:1311–1333. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mo XB, Wu LF, Lu X, Zhu XW, Xia W, Wang L,
He P, Bing PF, Zhang YH, Deng FY, et al: Detection of lncRNA-mRNA
interaction modules by integrating eQTL with weighted gene
co-expression network analysis. Funct Integr Genomics. 19:217–225.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Zhang X, Yang C, Cui S, Shen Q and
Xu S: The lncRNA RHPN1-AS1 downregulation promotes gefitinib
resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC. Cell
Cycle. 17:1772–1783. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu L, Yu X, Zhang L, Ding X, Pan H, Wen X,
Xu S, Xing Y, Fan J, Ge S, et al: The long non-coding RNA RHPN1-AS1
promotes uveal melanoma progression. Int J Mol Sci. 18:2262017.
View Article : Google Scholar
|
|
11
|
Xu C, Ping Y, Zhao H, Ning S, Xia P, Wang
W, Wan L, Li J, Zhang L, Yu L and Xiao Y: LncNetP, a systematical
lncRNA prioritization approach based on ceRNA and disease phenotype
association assumptions. Oncotarget. 8:114603–114612. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Duan H, Li X, Chen Y, Wang Y and Li Z:
LncRNA RHPN1-AS1 promoted cell proliferation, invasion and
migration in cervical cancer via the modulation of miR-299-3p/FGF2
axis. Life Sci. 239:1168562019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fen H, Hongmin Z, Wei W, Chao Y, Yang Y,
Bei L and Zhihua S: RHPN1-AS1 drives the progression of
hepatocellular carcinoma via regulating miR-596/IGF2BP2 axis. Curr
Pharm Des. 25:4630–4640. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cui P, Su J, Li Q, Xu G and Zhu N: LncRNA
RHPN1-AS1 targeting miR-625/REG3A promotes cell proliferation and
invasion of glioma cells. OncoTargets Ther. 12:7911–7921. 2019.
View Article : Google Scholar
|
|
15
|
Wesseling P and Capper D: WHO 2016
Classification of gliomas. Neuropathol Appl Neurobiol. 44:139–150.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dimberg A: The glioblastoma vasculature as
a target for cancer therapy. Biochem Soc Trans. 42:1647–1652. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Z, Lu Y, Xu Q, Tang B, Park CK and
Chen X: HULC and H19 played different roles in overall and
disease-free survival from hepatocellular carcinoma after curative
hepatectomy: A preliminary analysis from gene expression omnibus.
Dis Markers. 2015:1910292015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Meng H, Bai Y and Wang K: Regulation
of lncRNA and its role in cancer metastasis. Oncol Res. 23:205–217.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li C, Lei B, Huang S, Zheng M, Liu Z, Li Z
and Deng Y: H19 derived microRNA-675 regulates cell proliferation
and migration through CDK6 in glioma. Am J Transl Res. 7:1747–1764.
2015.PubMed/NCBI
|
|
21
|
Wang Y, Wang Y, Li J, Zhang Y, Yin H and
Han B: CRNDE, a long-noncoding RNA, promotes glioma cell growth and
invasion through mTOR signaling. Cancer Lett. 367:122–128. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Sun Y, Peng R, Liu H, He W, Zhang
L, Peng H and Zhang Z: The long noncoding RNA 150Rik promotes
mesangial cell proliferation via miR-451/IGF1R/p38 MAPK signaling
in diabetic nephropathy. Cell Physiol Biochem. 51:1410–1428. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong X, Fang Z, Yu M, Zhang L, Xiao R, Li
X, Pan G and Liu J: Knockdown of long noncoding RNA HOXA-AS2
suppresses chemoresistance of acute myeloid leukemia via the
miR-520c-3p/S100A4 Axis. Cell Physiol Biochem. 51:886–896. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Powers AS: Adult neurogenesis in mammals
and nonmammals. Commentary on Kempermann G (2012): New neurons for
‘survival of the fittest’. Nat Rev Neurosci 13:727-736. Brain Behav
Evol. 81:206–208. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weng J, Tu M, Wang P, Zhou X, Wang C, Wan
X, Zhou Z, Wang L, Zheng X, Li J, et al: Corrigendum to ‘Amiodarone
induces cell proliferation and myofibroblast differentiation via
ERK1/2 and p38 MAPK signaling in fibroblasts’ [Biomed.
Pharmacother. 115 (2019) 108889]. Biomed Pharmacother.
118:1090852019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei N, Wei H and Zhang H: Long non-coding
RNA ZEB1-AS1 promotes glioma cell proliferation, migration and
invasion through regulating miR-577. Eur Rev Med Pharmacol Sci.
22:3085–3093. 2018.PubMed/NCBI
|
|
27
|
Zheng S, Lv P, Su J, Miao K, Xu H and Li
M: Silencing of the long non-coding RNA RHPN1-AS1 suppresses the
epithelial-to-mesenchymal transition and inhibits breast cancer
progression. Am J Transl Res. 11:3505–3517. 2019.PubMed/NCBI
|
